Extends Horizon’s biomanufacturing capabilities into vaccine manufacture. Research supported by a grant from the Canadian International Development Research Centre, funded by the Bill and Melinda Gates foundation...
International medical imaging IT and cybersecurity company Sectra announces that the nationwide telepathology solution in the Netherlands is now ready for use by the country’s pathology labs. The solution aims to make images and reports digitally available for consultations, revisions and expert panels....
Calling All Antibiotic Resistance Researchers. Antibiotic Research UK (ANTRUK) the world’s first charity tackling bacterial antibiotic resistance invites researchers to apply for a grant under our Small Research Grants scheme...
This event will include presentations on the latest technologies for enhancing sample introduction and productivity together with tutorial talks on ICP-OES and ICP-MS theory and practice, as well as hands on laboratory work....
Deciphering the ‘Mosaic’ of the Brain. Researchers from the University of Leicester have shed new light on how neurons in the brain communicate with one another. This could potentially help in our understanding of how and why a range of neurodegenerative diseases occur....
Boulting Environmental Services completes Indivior R&D facility build. Cleanroom and laboratory design and construction specialist, Boulting Environmental Services (BES) has completed a £13 million project for global pharmaceutical business and world leader in the treatment of opioid addiction, Indivior....
Working to increase collaboration between the healthcare sector and academia to drive translational biomedical research at the University of Leicester. The College of Life Sciences at the University of Leicester has successfully secured over £1M from two Medical Research Council (MRC) translational funding schemes....
Protagen AG and Gustave Roussy have today announced the start of a collaboration to utilize Protagen’s SeroTag® technology to help identify biomarkers that predict and monitor immune-related adverse events (irAEs) in cancer patients treated with checkpoint inhibitors....
Nosopharm, a company dedicated to the research and development of new anti-infective drugs, and the University of Illinois at Chicago (UIC) announce the publication of a study in Molecular Cell on the mechanism of action of odilorhabdins, a new class of antibiotics to combat antibiotic resistance....
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program...
Collaboration will explore use of Breath Biopsy to identify novel biomarkers to enable personalized medicine applications. Owlstone Medical, a diagnostics company developing a breathalyzer for disease, has announced it has signed a service agreement with AstraZeneca plc...
Asynt reports on how a DrySyn OCTO 8-position parallel synthesiser has benefited early stage discovery chemistry at Cancer Research UK (Cambridge, UK). Designed to work with any hotplate stirrer, the DrySyn Octo has enabled the CRUK Therapeutic Discovery Laboratories to increase the productivity of their small-scale synthetic reactions....
IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, has announced that it will collaborate with IGEM Therapeutics (IGEM), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer....
Genevac reports on how Eurofins Biomnis has, using a miVac Quattro concentrator and SpeedTrap frost-free cold trap, considerably improved sample preparation productivity in its specialised clinical pathology laboratory....
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, has announced Oxford BioMedica® plc, a leading gene and cell therapy group, has invested in two Gyrolab xPlore™ systems....
Scientists at the University of Dundee have identified the effects of a mutation that gives rise to a form of Intellectual Disability. Intellectual Disability is a type of developmental brain disorder in young patients which to date remains poorly understood and is incurable. Researchers in the School of Life Sciences at Dundee focussed on mutations in the OGT gene, which plays a critical role in protecting brain cells against stress. In patients harbouring...
Researchers at Okayama University describe in the journal Scientific Reports the role of an extracellular protein, versican, in regulating tumor growth and providing a newly formed network of blood vessels to further nourish the tumor. Angiogenesis is the creation of new blood vessels from the branching of pre-existing ones....
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research of Professor Taiji Adachi which uses the JPK NanoWizard® AFM to understand the mechanical basis of mechanotransduction at...
Attana and University College of Dublin collaborated between 2014 and 2017 on the EU-funded project NanoClassifier. The project aimed at developing new methods for evaluation and screening of nanoparticles for therapeutic applications....
With exclusive rights to sell purified human 20S proteasome, a promising target for hematological malignancy treatment and cancer drug development, NovAliX will also provide structural biology analysis by X-ray crystallography of the protein complex....
Sterghios Moschos, Associate Professor in Cellular and Molecular Sciences at Northumbria University discusses the benefits of gene therapies and the financial implications of treatments. If you were born with a rare form of blindness, there is now a treatment for you that may restore your eyesight. That’s because gene therapies became a clinical reality in 2017. Yet many people with rare diseases that could be treated in this way may never benefit from these therapies because they are too expensive for drug companies to develop...
SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company’s recently incorporated US entity, SpeeDx Inc...
Extends Horizon’s biomanufacturing capabilities into vaccine manufacture. 
International medical imaging IT and cybersecurity company Sectra announces that the nationwide telepathology solution in the Netherlands is now ready for use by the country’s pathology labs. The solution aims to make images and reports digitally available for consultations, revisions and expert panels....
Calling All Antibiotic Resistance Researchers. Antibiotic Research UK (ANTRUK) the world’s first charity tackling bacterial antibiotic resistance invites researchers to apply for a grant under our Small Research Grants scheme...
This event will include presentations on the latest technologies for enhancing sample introduction and productivity together with tutorial talks on ICP-OES and ICP-MS theory and practice, as well as hands on laboratory work....
Deciphering the ‘Mosaic’ of the Brain. Researchers from the University of Leicester have shed new light on how neurons in the brain communicate with one another. This could potentially help in our understanding of how and why a range of neurodegenerative diseases occur....
Boulting Environmental Services completes Indivior R&D facility build. Cleanroom and laboratory design and construction specialist, Boulting Environmental Services (BES) has completed a £13 million project for global pharmaceutical business and world leader in the treatment of opioid addiction, Indivior....
Working to increase collaboration between the healthcare sector and academia to drive translational biomedical research at the University of Leicester. The College of Life Sciences at the University of Leicester has successfully secured over £1M from two Medical Research Council (MRC) translational funding schemes....
Protagen AG and Gustave Roussy have today announced the start of a collaboration to utilize Protagen’s SeroTag® technology to help identify biomarkers that predict and monitor immune-related adverse events (irAEs) in cancer patients treated with checkpoint inhibitors....
Nosopharm, a company dedicated to the research and development of new anti-infective drugs, and the University of Illinois at Chicago (UIC) announce the publication of a study in Molecular Cell on the mechanism of action of odilorhabdins, a new class of antibiotics to combat antibiotic resistance....
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program...
Collaboration will explore use of Breath Biopsy to identify novel biomarkers to enable personalized medicine applications. Owlstone Medical, a diagnostics company developing a breathalyzer for disease, has announced it has signed a service agreement with AstraZeneca plc...
Asynt reports on how a DrySyn OCTO 8-position parallel synthesiser has benefited early stage discovery chemistry at Cancer Research UK (Cambridge, UK). Designed to work with any hotplate stirrer, the DrySyn Octo has enabled the CRUK Therapeutic Discovery Laboratories to increase the productivity of their small-scale synthetic reactions....
IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, has announced that it will collaborate with IGEM Therapeutics (IGEM), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer....
Genevac reports on how Eurofins Biomnis has, using a miVac Quattro concentrator and SpeedTrap frost-free cold trap, considerably improved sample preparation productivity in its specialised clinical pathology laboratory....
Scientists at the University of Dundee have identified the effects of a mutation that gives rise to a form of Intellectual Disability. Intellectual Disability is a type of developmental brain disorder in young patients which to date remains poorly understood and is incurable. 
Researchers at Okayama University describe in the journal Scientific Reports the role of an extracellular protein, versican, in regulating tumor growth and providing a newly formed network of blood vessels to further nourish the tumor. Angiogenesis is the creation of new blood vessels from the branching of pre-existing ones....
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research of Professor Taiji Adachi which uses the JPK NanoWizard® AFM to understand the mechanical basis of mechanotransduction at...
Attana and University College of Dublin collaborated between 2014 and 2017 on the EU-funded project NanoClassifier. The project aimed at developing new methods for evaluation and screening of nanoparticles for therapeutic applications....
With exclusive rights to sell purified human 20S proteasome, a promising target for hematological malignancy treatment and cancer drug development, NovAliX will also provide structural biology analysis by X-ray crystallography of the protein complex....
Sterghios Moschos, Associate Professor in Cellular and Molecular Sciences at Northumbria University discusses the benefits of gene therapies and the financial implications of treatments. If you were born with a rare form of blindness, there is now a treatment for you that may restore your eyesight. That’s because gene therapies became a clinical reality in 2017. Yet many people with rare diseases that could be treated in this way may never benefit from these therapies because they are too expensive for drug companies to develop...
SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company’s recently incorporated US entity, SpeeDx Inc...